In This Issue
Thymic Tumors
Forty Years of the International Association for Study of Lung Cancer Pathology Committee
NSCLC and HER2
Generation and Sequencing of Pulmonary Carcinoid Tumor Cell Lines
A Comprehensive Investigation of Molecular Features and Prognosis of Lung Adenocarcinoma with Micropapillary Component
Prognostic Factors Based on Clinicopathological Data Among the Patients with Resected Peripheral Squamous Cell Carcinomas of the Lung
Comparative Effectiveness of Intensity-Modulated Versus 3D Conformal Radiation Therapy Among Medicare Patients with Stage III Lung Cancer
Long-Term Results after Treatment for Recurrent Thymoma
Development of the International Thymic Malignancy Interest Group International Database
Phase II Study of Amrubicin Combined with Carboplatin for Thymic Carcinoma and Invasive Thymoma
Clinical Characteristics and Outcomes for Patients With Thymic Carcinoma
Assessment of ALK Status by FISH on 1000 Spanish Non-Small Cell Lung Cancer Patients
Identification of a Novel HIP1-ALK Fusion Variant in Non–Small-Cell Lung Cancer (NSCLC) and Discovery of ALK I1171 (I1171N/S) Mutations in Two ALK-Rearranged NSCLC Patients with Resistance to Alectinib
Resection of a Solitary Pulmonary Metastasis from Prostatic Adenocarcinoma Misdiagnosed as a Bronchocele
Secondary Mutations at I1171 in the ALK Gene Confer Resistance to Both Crizotinib and Alectinib